M.B.H. Youdim

1.6k total citations · 1 hit paper
29 papers, 1.3k citations indexed

About

M.B.H. Youdim is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, M.B.H. Youdim has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Clinical Biochemistry. Recurrent topics in M.B.H. Youdim's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological and metabolic disorders (6 papers) and Metabolism and Genetic Disorders (5 papers). M.B.H. Youdim is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological and metabolic disorders (6 papers) and Metabolism and Genetic Disorders (5 papers). M.B.H. Youdim collaborates with scholars based in Israel, Germany and Austria. M.B.H. Youdim's co-authors include Peter Riederer, G. Hebenstreit, Gavin P. Reynolds, Helmut Heinsen, H. Beckmann, E. Sofić, M. Gerlach, Shlomo Yehuda, Dorit Ben‐Shachar and J. Sian and has published in prestigious journals such as Annals of the New York Academy of Sciences, Life Sciences and European Journal of Pharmacology.

In The Last Decade

M.B.H. Youdim

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1988 591 citations E. Sofić, Peter Riederer et al. Journal of Neural Transmission profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.B.H. Youdim Israel	13	676	365	326	266	218	29	1.3k
F. Agid France	5	667 1.0×	388 1.1×	351 1.1×	247 0.9×	222 1.0×	7	1.3k
Vera Dias Portugal	7	560 0.8×	305 0.8×	527 1.6×	208 0.8×	301 1.4×	7	1.5k
G. Hebenstreit Germany	9	445 0.7×	397 1.1×	412 1.3×	200 0.8×	168 0.8×	20	1.2k
P. Jenner United Kingdom	17	956 1.4×	753 2.1×	480 1.5×	254 1.0×	245 1.1×	26	1.8k
Huamin Xu China	25	513 0.8×	306 0.8×	577 1.8×	275 1.0×	222 1.0×	58	1.6k
M.B.H. Youdim Israel	18	836 1.2×	654 1.8×	448 1.4×	361 1.4×	304 1.4×	28	1.8k
E. J. Mufson United States	9	196 0.3×	438 1.2×	500 1.5×	290 1.1×	517 2.4×	11	1.6k
Shenggang Sun China	23	494 0.7×	498 1.4×	569 1.7×	401 1.5×	460 2.1×	88	1.9k
Lucia Petrozzi Italy	28	475 0.7×	360 1.0×	875 2.7×	253 1.0×	543 2.5×	55	2.0k
Pekka Rauhala Finland	23	250 0.4×	477 1.3×	418 1.3×	166 0.6×	596 2.7×	66	1.6k

Countries citing papers authored by M.B.H. Youdim

Since Specialization

Citations

This map shows the geographic impact of M.B.H. Youdim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B.H. Youdim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B.H. Youdim more than expected).

Fields of papers citing papers by M.B.H. Youdim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.B.H. Youdim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B.H. Youdim. The network helps show where M.B.H. Youdim may publish in the future.

Co-authorship network of co-authors of M.B.H. Youdim

This figure shows the co-authorship network connecting the top 25 collaborators of M.B.H. Youdim. A scholar is included among the top collaborators of M.B.H. Youdim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.B.H. Youdim. M.B.H. Youdim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Youdim, M.B.H., et al.. (2015). Environmental factors and movement disorders. Journal of the Neurological Sciences. 357. e477–e478.

2.

Youdim, M.B.H.. (2006). My love with monoamine oxidase, iron and Parkinson's disease.. PubMed. V–IX. 5 indexed citations

3.

Foley, Peter, M. Gerlach, M.B.H. Youdim, & Peter Riederer. (2000). MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?. Parkinsonism & Related Disorders. 6(1). 25–47. 79 indexed citations

4.

Double, Kay L., M. Gerlach, M.B.H. Youdim, & Peter Riederer. (2000). Impaired iron homeostasis in Parkinson’s disease. PubMed. 37–58. 83 indexed citations

5.

Naoi, Makoto, W. Maruyama, Kiyohito Yagi, & M.B.H. Youdim. (2000). Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds.. PubMed. 8(1). 69–80. 12 indexed citations

6.

Carrillo, Marı́a C., Kenichi Kitani, W. Maruyama, et al.. (2000). Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. Life Sciences. 67(5). 577–585. 98 indexed citations

7.

Youdim, M.B.H., et al.. (1999). The Future of Neuroprotection. Annals of the New York Academy of Sciences. 890(1). 529–533. 37 indexed citations

8.

Sian, J., M. Gerlach, M.B.H. Youdim, & Peter Riederer. (1999). Parkinson's disease: a major hypokinetic basal ganglia disorder. Journal of Neural Transmission. 106(5). 443–443. 72 indexed citations

9.

Sian, J., M.B.H. Youdim, Peter Riederer, & M. Gerlach. (1999). MPTP-Induced Parkinsonian Syndrome. 11 indexed citations

10.

Youdim, M.B.H., et al.. (1999). Drug- Or Toxin-Induced Movement Disorders. 1 indexed citations

11.

Sian, J., et al.. (1999). Amyotrophic Lateral Sclerosis—Parkinsonism—Dementia of Guam. 1 indexed citations

12.

Coleman, Raymond, et al.. (1995). Ultrastructural Changes in Mitochondria of the Adrenal Cortex of Iron-Deficient Rats. Cells Tissues Organs. 152(1). 33–40. 7 indexed citations

13.

Youdim, M.B.H. & Peter Riederer. (1993). The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in parkinson's disease. Movement Disorders. 8(S1). S8–S13. 20 indexed citations

14.

Youdim, M.B.H., Dorit Ben‐Shachar, & Peter Riederer. (1993). Iron-Melanin Interaction and Parkinson's Disease. Physiology. 8(1). 45–49. 10 indexed citations

15.

Jellinger, K. A., E. Kienzl, Werner Paulus, et al.. (1993). Iron and ferritin in substantia nigra in Parkinson's disease.. PubMed. 60. 267–72. 67 indexed citations

16.

Riederer, Peter, et al.. (1990). Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkey. Neurochemistry International. 17(2). 325–329. 9 indexed citations

17.

Sofić, E., Peter Riederer, Helmut Heinsen, et al.. (1988). Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. Journal of Neural Transmission. 74(3). 199–205. 591 indexed citations breakdown →

18.

Youdim, M.B.H. & Dorit Ben‐Shachar. (1987). Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission.. PubMed. 23(1-2). 19–25. 26 indexed citations

19.

Youdim, M.B.H.. (1985). Prevention of 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine induced neurotoxicity by agn 1133 and agn 1135 selective inhibitors of monoamine oxidase b. European Journal of Pharmacology. 313–318. 1 indexed citations

20.

Youdim, M.B.H., et al.. (1974). Enhanced tyramine conjugation in Parkinson's disease. Clinica Chimica Acta. 51(3). 327–329. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact